21，Coplen SE，Antman EM,Berlin JA.Efficacy and safe of quinidine therapy for maintenance of sinus rhythm after cardioversion.Circula tion,1990.82(4)∶1106.
32，Flaker GC,Blackshe ar JL,McBRIDE R.Antiarrhymic drug therapy and cardiac mortality in atrial fibril lation.J Am Coll Cardiol,1992,20(3)∶527.
43，Ceremjuzyski Y,Klechzar E,Kreminska-Pakula M.Eff ects of amiodarone on mortality after myocardial infarction.J Am Coll Cardiol,19 92.20(4)∶1056.
54，Singh SN,Fletcher RD,Fisher SG,et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricula r arrhythmia.N Engl J Med,1995,333(2)∶77.
65，Doval HC,Nul DR,Grancelli HO,et al.In sufficiency cardiac on argentina(GESICA).Randomized trial of low-dose amiodaron e in severe congestive heart failure.Lancet,1994,334(8291)∶493.
76，Cui G,Sen L,Sager P.Effects of amiodarone,sematil ide and sotalol on QT dispersion.Am J cardiol,1994,74(9)∶896.
87，Dritsas A,Gilligan P,Nihoyannopoulos P.Amiodarone reduce QT dispersion in patients with hypertrophic cardiomyopathy.Int J Cardiol ,1992,36(4)∶345.
98，Hii JT,Wyse DG,Gillis AM.Percordial QT interval d ispersion as a marker of torsade de pointes,Pisparate effects of class I a antia rrhythmic drug and amiodarone.Circulation,1992,86(5)∶1376.
109，Grimm W,Steder U,Menz V.Effects of amiodarone on QT dispersion in the 12-leads standard electrocardiogram and its significance f or subsequent arrhythmic events.Clin cardiol,1997,20(2)∶107.
